Dear Editor, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a
severe threat to global health. 1 The spike (S) protein on the surface of SARS-CoV-2 exploits …

SARS-CoV-2 spike (S) glycoprotein is the key target of current vaccine development efforts
to combat COVID-19; neutralizing antibodies bind S and interfere with S binding to its …

The spike protein (S-protein) of SARS-CoV-2, the protein that enables the virus to infect
human cells, is the basis for many vaccines and a hotspot of concerning virus evolution …

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has recently emerged
in China and caused a disease called coronavirus disease 2019 (COVID-19). The virus …

Dear Editor, Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has resulted in a severe global pandemic. Following …

Viral spike proteins play important roles in the viral entry process, facilitating attachment to
cellular receptors and fusion of the viral envelope with the cell membrane. Severe acute …

The spread of COVID-19 caused by the SARS-CoV-2 outbreak has been growing since its
first identification in December 2019. The publishing of the first SARS-CoV-2 genome made …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped virus
which binds its cellular receptor angiotensin-converting enzyme 2 (ACE2) and enters hosts …

The year 2020 has seen a major and sustained outbreak of a novel betacoronavirus (severe
acute respiratory syndrome (SARS)-coronavirus (CoV)-2) infection that causes fever, severe …

Abstract SARS‐CoV‐2 spike protein (S) binds to human angiotensin‐converting enzyme 2
(hACE2), allowing virus to dock on cell membrane follow by viral entry. Here, we use high …